Steris (STE) Share-based Compensation Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 23.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.63% |
| Dec 31, 2025 | 2.61% |
| Sep 30, 2025 | 1.92% |
| Jun 30, 2025 | 3.48% |
| Mar 31, 2025 | 9.50% |
| Dec 31, 2024 | 0.05% |
| Sep 30, 2024 | 0.41% |
| Jun 30, 2024 | -0.68% |
| Mar 31, 2024 | -1.62% |
| Dec 31, 2023 | 63.63% |
| Sep 30, 2023 | 79.39% |
| Jun 30, 2023 | 29.19% |
| Mar 31, 2023 | -6.74% |
| Dec 31, 2022 | -6.53% |
| Sep 30, 2022 | 2.10% |
| Jun 30, 2022 | -66.30% |
| Mar 31, 2022 | 61.39% |
| Dec 31, 2021 | 66.01% |
| Sep 30, 2021 | 42.46% |
| Jun 30, 2021 | 346.16% |
| Mar 31, 2021 | 22.09% |
| Dec 31, 2020 | 7.82% |
| Sep 30, 2020 | 2.58% |
| Jun 30, 2020 | 7.68% |
| Mar 31, 2020 | -11.75% |
| Dec 31, 2019 | 3.08% |
| Sep 30, 2019 | 0.49% |
| Jun 30, 2019 | 5.73% |